StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $406.23MP/E –Yield –

Earnings

Vireo Growth's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 16, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$253.70M
+176.7% on a year earlier
EPS, Q3 FY2026
–
Latest guidance
Issued
Nov 10, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Vireo Growth's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 16, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 10, 2026before the open$253.70M+176.7%–Release
Q2 FY2026ended Jun 30, 2026Aug 11, 2026before the open$209.30M+335.1%–Release
Q1 FY2026ended Mar 31, 2026May 12, 2026before the open$106.20M+333.5%–Release
Q4 FY2025ended Dec 31, 2025Mar 17, 2026before the open$104.50M+318.0%–Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open$91.70M––Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025before the open$48.10M––Release
Q1 FY2025ended Mar 31, 2025May 9, 2025before the open$24.50M–-$0.02Release
Q4 FY2024ended Dec 31, 2024Mar 4, 2025before the open$25.00M––Release
Q1 FY2023ended Mar 31, 2023May 19, 2023before the open–––Release
Q4 FY2022ended Dec 31, 2022Apr 6, 2023after the close–––Release
Q3 FY2022ended Sep 30, 2022Nov 15, 2022during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Vireo Growth's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueQ4 FY2026$250.00M – $265.00M–NewNov 10, 2026
Adjusted EBITDAnon-GAAPQ4 FY2026$45.00M – $48.00M–NewNov 10, 2026
revenueQ1 FY2027$280.00M – $300.00M–NewNov 10, 2026
Adjusted EBITDAnon-GAAPQ1 FY2027$53.00M – $56.00M–NewNov 10, 2026

Guidance history

Every forecast Vireo Growth put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 10, 2026Adjusted EBITDAQ4 FY2026$45.00M – $48.00MNew
Nov 10, 2026Adjusted EBITDAQ1 FY2027$53.00M – $56.00MNew
Nov 10, 2026revenueQ4 FY2026$250.00M – $265.00MNew
Nov 10, 2026revenueQ1 FY2027$280.00M – $300.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Vireo Growth filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Results
  3. Update
  4. Update
  5. Update
  6. Update
  7. Update
  8. Results
  9. Update
  10. News
  11. Update
  12. Update
  13. Update
  14. Update
  15. Update

See a number that looks wrong?